nodes	percent_of_prediction	percent_of_DWPC	metapath
Medroxyprogesterone Acetate—ESR1—osteoarthritis	0.957	1	CbGaD
Medroxyprogesterone Acetate—AKR1C3—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—PTGES—osteoarthritis	0.0056	0.145	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Arachidonic acid metabolism—PTGES—osteoarthritis	0.00202	0.0524	CbGpPWpGaD
Medroxyprogesterone Acetate—Ethynodiol—ESR1—osteoarthritis	0.00194	0.485	CrCbGaD
Medroxyprogesterone Acetate—AKR1C3—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—PTGS2—osteoarthritis	0.0011	0.0285	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Adipogenesis—FRZB—osteoarthritis	0.000962	0.0249	CbGpPWpGaD
Medroxyprogesterone Acetate—Fluoxymesterone—ESR1—osteoarthritis	0.000961	0.241	CrCbGaD
Medroxyprogesterone Acetate—PGR—Ovarian Infertility Genes—SMAD3—osteoarthritis	0.000764	0.0198	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Notch-mediated HES/HEY network—BGLAP—osteoarthritis	0.00072	0.0186	CbGpPWpGaD
Medroxyprogesterone Acetate—Drospirenone—PTGS2—osteoarthritis	0.000617	0.155	CrCbGaD
Medroxyprogesterone Acetate—HSD3B2—Metabolism of lipids and lipoproteins—PTGES—osteoarthritis	0.000586	0.0152	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Arachidonic acid metabolism—PTGES—osteoarthritis	0.000569	0.0147	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Cellular roles of Anthrax toxin—IL1B—osteoarthritis	0.000562	0.0145	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Tryptophan metabolism—ALDH1A2—osteoarthritis	0.000554	0.0143	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Nuclear Receptors—ESR1—osteoarthritis	0.000543	0.0141	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Nuclear signaling by ERBB4—ESR1—osteoarthritis	0.000532	0.0138	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Metapathway biotransformation—GSTO1—osteoarthritis	0.000523	0.0135	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Transcription factor regulation in adipogenesis—LEP—osteoarthritis	0.000509	0.0132	CbGpPWpGaD
Medroxyprogesterone Acetate—HSD3B2—Corticotropin-releasing hormone—CXCL8—osteoarthritis	0.000479	0.0124	CbGpPWpGaD
Medroxyprogesterone Acetate—Progesterone—ESR1—osteoarthritis	0.000476	0.119	CrCbGaD
Medroxyprogesterone Acetate—CYP2C9—Arachidonic acid metabolism—PTGES—osteoarthritis	0.000463	0.012	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Nuclear Receptor transcription pathway—ESR1—osteoarthritis	0.000429	0.0111	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Nuclear Receptors—ESR1—osteoarthritis	0.000414	0.0107	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Cellular roles of Anthrax toxin—TNF—osteoarthritis	0.000408	0.0106	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Arachidonic acid metabolism—PTGS2—osteoarthritis	0.000397	0.0103	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—FOXA1 transcription factor network—ESR1—osteoarthritis	0.000368	0.00953	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Validated nuclear estrogen receptor alpha network—ESR1—osteoarthritis	0.000358	0.00927	CbGpPWpGaD
Medroxyprogesterone Acetate—HSD3B2—Corticotropin-releasing hormone—TGFB1—osteoarthritis	0.000357	0.00924	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Glucocorticoid receptor regulatory network—BGLAP—osteoarthritis	0.00035	0.00906	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—AP-1 transcription factor network—TIMP1—osteoarthritis	0.000341	0.00882	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—AP-1 transcription factor network—TIMP1—osteoarthritis	0.000335	0.00869	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Leptin signaling pathway—IL1RN—osteoarthritis	0.000329	0.00853	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Nuclear Receptor transcription pathway—ESR1—osteoarthritis	0.000327	0.00847	CbGpPWpGaD
Medroxyprogesterone Acetate—HSD3B2—Metabolism—FMOD—osteoarthritis	0.00032	0.00828	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Signaling events mediated by HDAC Class II—ESR1—osteoarthritis	0.000314	0.00813	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Nuclear Receptors—ESR1—osteoarthritis	0.000314	0.00813	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Metabolism of lipids and lipoproteins—PTGES—osteoarthritis	0.000289	0.00749	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Regulation of nuclear SMAD2/3 signaling—SMAD3—osteoarthritis	0.000277	0.00717	CbGpPWpGaD
Medroxyprogesterone Acetate—HSD3B2—Metabolism—PTGES—osteoarthritis	0.000261	0.00675	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Plasma membrane estrogen receptor signaling—IGF1—osteoarthritis	0.00026	0.00673	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Androgen receptor signaling pathway—SMAD3—osteoarthritis	0.000257	0.00665	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Plasma membrane estrogen receptor signaling—MMP2—osteoarthritis	0.000251	0.00651	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Nuclear Receptor transcription pathway—ESR1—osteoarthritis	0.000248	0.00643	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—FOXM1 transcription factor network—MMP2—osteoarthritis	0.000247	0.00638	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Regulation of Telomerase—SMAD3—osteoarthritis	0.000245	0.00635	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling mediated by p38-alpha and p38-beta—PTGS2—osteoarthritis	0.000244	0.00633	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Endoderm Differentiation—SMAD3—osteoarthritis	0.000242	0.00626	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—SIDS Susceptibility Pathways—IL1RN—osteoarthritis	0.000238	0.00616	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Transcription factor regulation in adipogenesis—TNF—osteoarthritis	0.000236	0.0061	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Adipogenesis—BMP2—osteoarthritis	0.000229	0.00594	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Regulation of nuclear SMAD2/3 signaling—ESR1—osteoarthritis	0.000226	0.00585	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Regulation of nuclear SMAD2/3 signaling—SMAD3—osteoarthritis	0.000213	0.00552	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—AP-1 transcription factor network—MMP1—osteoarthritis	0.000212	0.00548	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Regulation of nuclear SMAD2/3 signaling—SMAD3—osteoarthritis	0.00021	0.00544	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—AP-1 transcription factor network—MMP1—osteoarthritis	0.000209	0.0054	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Aryl Hydrocarbon Receptor—PTGS2—osteoarthritis	0.000196	0.00509	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Leptin signaling pathway—LEP—osteoarthritis	0.000194	0.00502	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—AP-1 transcription factor network—ESR1—osteoarthritis	0.000193	0.00499	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MMP2—osteoarthritis	0.000191	0.00495	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Transcription factor regulation in adipogenesis—IL6—osteoarthritis	0.00019	0.00492	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Plasma membrane estrogen receptor signaling—MMP9—osteoarthritis	0.000189	0.00489	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—FMOD—osteoarthritis	0.000189	0.00488	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—ATF-2 transcription factor network—MMP2—osteoarthritis	0.000188	0.00486	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Glucocorticoid receptor regulatory network—MMP1—osteoarthritis	0.000184	0.00476	CbGpPWpGaD
Medroxyprogesterone Acetate—HSD3B2—Metabolism—GSTO1—osteoarthritis	0.000184	0.00476	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—SIDS Susceptibility Pathways—IL1RN—osteoarthritis	0.000181	0.00467	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling by ERBB4—ESR1—osteoarthritis	0.000179	0.00464	CbGpPWpGaD
Medroxyprogesterone Acetate—HSD3B2—Metabolism—BGN—osteoarthritis	0.000178	0.00461	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Regulation of nuclear SMAD2/3 signaling—ESR1—osteoarthritis	0.000171	0.00444	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—SIDS Susceptibility Pathways—IL1A—osteoarthritis	0.000171	0.00443	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—IHH—osteoarthritis	0.000168	0.00435	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CXCL8—osteoarthritis	0.000159	0.00411	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Metabolism—FMOD—osteoarthritis	0.000158	0.00409	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—ATF-2 transcription factor network—CXCL8—osteoarthritis	0.000156	0.00404	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Biological oxidations—GSTO1—osteoarthritis	0.000149	0.00386	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Integrated Breast Cancer Pathway—MMP1—osteoarthritis	0.000149	0.00385	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metapathway biotransformation—GSTO1—osteoarthritis	0.000147	0.00381	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Adipogenesis—SMAD3—osteoarthritis	0.000144	0.00373	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MMP9—osteoarthritis	0.000144	0.00372	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Integrated Breast Cancer Pathway—ESR1—osteoarthritis	0.000137	0.00355	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—AP-1 transcription factor network—CXCL8—osteoarthritis	0.000136	0.00353	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—AP-1 transcription factor network—CXCL8—osteoarthritis	0.000134	0.00347	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Aryl Hydrocarbon Receptor—TNF—osteoarthritis	0.000133	0.00343	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—SIDS Susceptibility Pathways—IL1A—osteoarthritis	0.00013	0.00336	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Metabolism—PTGES—osteoarthritis	0.000129	0.00333	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—TGFBI—osteoarthritis	0.000125	0.00325	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Leptin signaling pathway—IL1B—osteoarthritis	0.000124	0.0032	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—AP-1 transcription factor network—MMP9—osteoarthritis	0.000123	0.00319	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Adipogenesis—LEP—osteoarthritis	0.000123	0.00318	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Biological oxidations—GSTO1—osteoarthritis	0.000121	0.00314	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—AP-1 transcription factor network—MMP9—osteoarthritis	0.000121	0.00314	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metapathway biotransformation—GSTO1—osteoarthritis	0.00012	0.0031	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Glucocorticoid receptor regulatory network—CXCL8—osteoarthritis	0.000118	0.00306	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—IHH—osteoarthritis	0.000118	0.00305	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—MCF2L—osteoarthritis	0.000118	0.00305	CbGpPWpGaD
Medroxyprogesterone Acetate—HSD3B2—Metabolism of lipids and lipoproteins—PTGS2—osteoarthritis	0.000115	0.00297	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Integrated Breast Cancer Pathway—MMP1—osteoarthritis	0.000114	0.00296	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Integrated Pancreatic Cancer Pathway—ESR1—osteoarthritis	0.000114	0.00295	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Arachidonic acid metabolism—PTGS2—osteoarthritis	0.000112	0.00289	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—GSTO1—osteoarthritis	0.000108	0.00281	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—BGN—osteoarthritis	0.000105	0.00272	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Regulation of Telomerase—TGFB1—osteoarthritis	0.000104	0.00269	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Endoderm Differentiation—TGFB1—osteoarthritis	0.000102	0.00265	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Adipogenesis—IGF1—osteoarthritis	0.000102	0.00263	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—AP-1 transcription factor network—TGFB1—osteoarthritis	0.000102	0.00263	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—AP-1 transcription factor network—TGFB1—osteoarthritis	0.0001	0.00259	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Integrated Pancreatic Cancer Pathway—IGF1—osteoarthritis	9.85e-05	0.00255	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—SIDS Susceptibility Pathways—CXCL8—osteoarthritis	9.31e-05	0.00241	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—IHH—osteoarthritis	9.29e-05	0.0024	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—MCF2L—osteoarthritis	9.29e-05	0.0024	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Generic Transcription Pathway—SMAD3—osteoarthritis	9.09e-05	0.00235	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Arachidonic acid metabolism—PTGS2—osteoarthritis	9.08e-05	0.00235	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Metabolism—GSTO1—osteoarthritis	9.07e-05	0.00235	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—SIDS Susceptibility Pathways—IL1B—osteoarthritis	8.93e-05	0.00231	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Metabolism—BGN—osteoarthritis	8.79e-05	0.00228	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—ATF-2 transcription factor network—IL6—osteoarthritis	8.77e-05	0.00227	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—COL9A2—osteoarthritis	8.64e-05	0.00224	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—COL9A1—osteoarthritis	8.39e-05	0.00217	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Integrated Pancreatic Cancer Pathway—PTGS2—osteoarthritis	8.17e-05	0.00211	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism of lipids and lipoproteins—PTGES—osteoarthritis	8.13e-05	0.00211	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Biological oxidations—GSTO1—osteoarthritis	8.01e-05	0.00207	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metapathway biotransformation—GSTO1—osteoarthritis	7.9e-05	0.00204	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—AP-1 transcription factor network—IL6—osteoarthritis	7.65e-05	0.00198	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Integrated Pancreatic Cancer Pathway—IGF1—osteoarthritis	7.59e-05	0.00196	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—AP-1 transcription factor network—IL6—osteoarthritis	7.53e-05	0.00195	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Generic Transcription Pathway—ESR1—osteoarthritis	7.42e-05	0.00192	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—SIDS Susceptibility Pathways—CXCL8—osteoarthritis	7.06e-05	0.00183	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling by ERBB4—IL6—osteoarthritis	7.01e-05	0.00181	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Generic Transcription Pathway—SMAD3—osteoarthritis	6.93e-05	0.00179	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—COL9A2—osteoarthritis	6.82e-05	0.00177	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—SIDS Susceptibility Pathways—IL1B—osteoarthritis	6.78e-05	0.00175	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Glucocorticoid receptor regulatory network—IL6—osteoarthritis	6.64e-05	0.00172	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—COL9A1—osteoarthritis	6.62e-05	0.00171	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism of lipids and lipoproteins—PTGES—osteoarthritis	6.62e-05	0.00171	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—SIDS Susceptibility Pathways—TNF—osteoarthritis	6.48e-05	0.00168	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Integrated Pancreatic Cancer Pathway—PTGS2—osteoarthritis	6.29e-05	0.00163	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Adipogenesis—TGFB1—osteoarthritis	6.09e-05	0.00158	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Integrated Pancreatic Cancer Pathway—TGFB1—osteoarthritis	5.9e-05	0.00153	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—BMP2—osteoarthritis	5.75e-05	0.00149	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Adipogenesis—TNF—osteoarthritis	5.69e-05	0.00147	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Metabolism of lipids and lipoproteins—PTGS2—osteoarthritis	5.67e-05	0.00147	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Generic Transcription Pathway—ESR1—osteoarthritis	5.65e-05	0.00146	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Integrated Pancreatic Cancer Pathway—TNF—osteoarthritis	5.51e-05	0.00143	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—IHH—osteoarthritis	5.45e-05	0.00141	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—MCF2L—osteoarthritis	5.45e-05	0.00141	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Generic Transcription Pathway—SMAD3—osteoarthritis	5.33e-05	0.00138	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Generic Transcription Pathway—SMAD3—osteoarthritis	5.25e-05	0.00136	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—SIDS Susceptibility Pathways—IL6—osteoarthritis	5.23e-05	0.00135	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—SMAD3—osteoarthritis	5.15e-05	0.00133	CbGpPWpGaD
Medroxyprogesterone Acetate—HSD3B2—Metabolism—PTGS2—osteoarthritis	5.12e-05	0.00132	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—SIDS Susceptibility Pathways—TNF—osteoarthritis	4.92e-05	0.00127	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Adipogenesis—IL6—osteoarthritis	4.59e-05	0.00119	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Integrated Pancreatic Cancer Pathway—TGFB1—osteoarthritis	4.55e-05	0.00118	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—BMP2—osteoarthritis	4.54e-05	0.00117	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—FMOD—osteoarthritis	4.44e-05	0.00115	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Gene Expression—SMAD3—osteoarthritis	4.38e-05	0.00113	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Generic Transcription Pathway—ESR1—osteoarthritis	4.29e-05	0.00111	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Integrated Pancreatic Cancer Pathway—TNF—osteoarthritis	4.25e-05	0.0011	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling by ERBB4—IL6—osteoarthritis	4.11e-05	0.00107	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—COL9A2—osteoarthritis	4e-05	0.00104	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—MMP3—osteoarthritis	3.99e-05	0.00103	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—SIDS Susceptibility Pathways—IL6—osteoarthritis	3.97e-05	0.00103	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—COL9A1—osteoarthritis	3.88e-05	0.00101	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—PTGES—osteoarthritis	3.62e-05	0.000938	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—FMOD—osteoarthritis	3.62e-05	0.000936	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—SMAD3—osteoarthritis	3.61e-05	0.000934	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Gene Expression—ESR1—osteoarthritis	3.57e-05	0.000925	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Gene Expression—SMAD3—osteoarthritis	3.33e-05	0.000863	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—MMP3—osteoarthritis	3.14e-05	0.000814	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—LEP—osteoarthritis	3.08e-05	0.000798	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—PTGS2—osteoarthritis	3.02e-05	0.000781	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—PTGES—osteoarthritis	2.95e-05	0.000763	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—ESR1—osteoarthritis	2.94e-05	0.000762	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—FN1—osteoarthritis	2.91e-05	0.000753	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—SMAD3—osteoarthritis	2.85e-05	0.000737	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Gene Expression—ESR1—osteoarthritis	2.72e-05	0.000704	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—BMP2—osteoarthritis	2.66e-05	0.000689	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Gene Expression—SMAD3—osteoarthritis	2.57e-05	0.000665	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—GSTO1—osteoarthritis	2.55e-05	0.000661	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—IGF1—osteoarthritis	2.55e-05	0.00066	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Gene Expression—SMAD3—osteoarthritis	2.53e-05	0.000655	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Metabolism—PTGS2—osteoarthritis	2.53e-05	0.000654	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—BGN—osteoarthritis	2.47e-05	0.00064	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—LEP—osteoarthritis	2.43e-05	0.00063	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—FMOD—osteoarthritis	2.38e-05	0.000617	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—ESR1—osteoarthritis	2.32e-05	0.000601	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—FN1—osteoarthritis	2.29e-05	0.000594	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—TGFB1—osteoarthritis	2.18e-05	0.000565	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—GSTO1—osteoarthritis	2.08e-05	0.000538	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Gene Expression—ESR1—osteoarthritis	2.06e-05	0.000534	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—CXCL8—osteoarthritis	2.05e-05	0.000531	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—BGN—osteoarthritis	2.01e-05	0.000521	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—IGF1—osteoarthritis	2.01e-05	0.00052	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—PTGES—osteoarthritis	1.94e-05	0.000503	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—MMP9—osteoarthritis	1.85e-05	0.00048	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—MMP3—osteoarthritis	1.85e-05	0.000478	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—SMAD3—osteoarthritis	1.67e-05	0.000432	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—IL6—osteoarthritis	1.64e-05	0.000426	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—CXCL8—osteoarthritis	1.62e-05	0.000418	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—osteoarthritis	1.6e-05	0.000413	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—TGFB1—osteoarthritis	1.53e-05	0.000395	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—MMP9—osteoarthritis	1.46e-05	0.000379	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—LEP—osteoarthritis	1.43e-05	0.00037	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—GSTO1—osteoarthritis	1.37e-05	0.000355	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—FN1—osteoarthritis	1.35e-05	0.000349	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—BGN—osteoarthritis	1.33e-05	0.000343	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—osteoarthritis	1.3e-05	0.000336	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—TGFB1—osteoarthritis	1.2e-05	0.000312	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—IGF1—osteoarthritis	1.18e-05	0.000305	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—IL6—osteoarthritis	1.15e-05	0.000298	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—CXCL8—osteoarthritis	9.49e-06	0.000246	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—IL6—osteoarthritis	9.08e-06	0.000235	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—MMP9—osteoarthritis	8.58e-06	0.000222	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—PTGS2—osteoarthritis	7.1e-06	0.000184	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—TGFB1—osteoarthritis	7.07e-06	0.000183	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—PTGS2—osteoarthritis	5.78e-06	0.00015	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—IL6—osteoarthritis	5.33e-06	0.000138	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—PTGS2—osteoarthritis	3.81e-06	9.87e-05	CbGpPWpGaD
